Patentes Consorcio SICI-Consolider 2009
Transcripción
Patentes Consorcio SICI-Consolider 2009
Patentes Consorcio SICI-Consolider 2009-2012 1) Inventors: Antonio Ferrer-Montiel, Asia Fernández-Carvajal, Belmonte Martínez, Félix Viana, Juana Gallar Titule: Composición farmacéutica para el tratamiento del ojo seco Institution: UMH (80%), CSIC (20%) Patent number: P2010-31341 (08/09/2010) Carlos, 2) Inventors: Antonio Ferrer-Montiel, Asia Fernández-Carvajal, Gregorio Fernandez Ballester, José Manuel González Ros, Carlos Belmonte Martínez, Félix Viana, Ana Gomis, Pierluigi Valente y María Camprubí-Robles. Title: Péptidos inhibidores de los termorreceptores Institution: UMH (50%), DiverDrugs (40%), CSIC (10%) Patent number: P2011-30052 3) Inventors: Antonio Ferrer-Montiel, Asia Fernández-Carvajal, Gregorio Fernandez Ballester, José Manuel González Ros, Carlos Belmonte Martínez, Félix Viana, Ana Gomis, Rosa María Planells-Cases, Miquel Vidal, Jordi Bujons, Angel Messeguer Title: Compuestos moduladores de los receptores TRP y sus usos Institution: UMH (33%), CSIC (33%), CIPF (33%) Patent number: P2011-30537 2012 International patent application: TRP modulating compounds and their uses Ferrer Montiel A, Fernández Carvajal A, González Ros JM, Belmonte Martínez C, Viana de la Iglesia F, Gomis Garcia A, Messeguer Peypoch A, Bujons Vilas J, Vidal Mosquera M, Planells Cases R.PCT/ES2012/070234 presented in 2012 4) Inventors: Vicente Felipo, Omar Cauli, María del Carmen Montoliu Title: Ex – vivo method for early diagnosis of minimal hepatic encephalopathy by measuring 3-nitrotyrosine in serum Patent number: P2010-00899 2012 International patent application: Ex vivo method for early diagnosis of minimal hepatic encephalopathy by measuring 3-nitrotyrosine in serum. Authors: Felipo V, Cauli, Montoliu C. Application: P201000899, July 12, 2010. PCT/ES2011/070509 published on January 19, 2012, WO2012007624 5) Inventors: Borges, R.; Montesinos, M.S.; Beltrán, B.; Machado J.D.; Fernández, Title: Sistema de detección de actividad biológica en tiempo real basado en cromatografía líquida Patent number: P2009-02287. 6) Inventors: Borges, R.; Rodríguez-Valido, M.; Machado J.D.; Beltrán, B.; Montesinos, M.S.; Díaz-Martín, D.; González Morales, Y. Title: Dispositivo y procedimiento para la evaluación múltiple y simultánea de la actividad contráctil de sustancias farmacológicas mediante métodos ópticos. Patent number: P201000640 7) Inventors: Hensall, David; Engel, Tobias; Diaz Hernandéz, Miguel; MirasPortugal, Maria Teresa Title: P2x7 antagonists as frontline or adjunctive treatment against status epilepticus Patent Number(s): European Patent Application Nº 11382386.8-2123 8) Inventors: Carlos Belmonte Martínez, Juana Gallar Martinez, Antonio Ferrer Montiel, Asia Fernández Carvajal, Felix Viana de la Iglesia Title: Composición farmacéutica para el tratamiento de la epifora Application number: 201131122. UMH-CSIC 2012 International patent application: Pharmaceutic composition for epiphora treatment. Belmonte Martínez C, Gallar Martinez J, Ferrer Montiel A, Asia Fernández Carvajal, Viana de la Iglesia F.PCT/ES02011/070627, WO2012/032209 A3, 2012 9) Inventors: Javier Burgueño, Francisco Ciruela and José Miguel Vela. Title: Method to identify ligands for sigma-1 receptors Application number: European Patent Application EP 12382003.7 filed on 10/01/2012 not yet published) Además, el consorcio está asesorando en la valorización y licencia de las solicitudes de patente: “Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses” (PCT/ES2007000120) (P18) “Pharmaceutical composition for treating axonal growth reduction or collateral loss, nervous lesion or synaptic connection loss, comprises P2X7 receptor antagonist which can cross blood brain barrier” (WO2010018280A1) (P23) “Diagnostic method and/or prognosis of Huntington's chorea comprises measuring proportion of P2X7 mRNA with respect to internal control; measuring the concentration of protein P2X7; and comparing these values with the normal pattern” (WO2008142194-A1).